Investigation of disease-free survival as a surrogate endpoint for survival in cancer clinical trials (Q3842893)

From MaRDI portal
Revision as of 15:53, 28 May 2024 by ReferenceBot (talk | contribs) (‎Changed an Item)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
scientific article
Language Label Description Also known as
English
Investigation of disease-free survival as a surrogate endpoint for survival in cancer clinical trials
scientific article

    Statements

    Investigation of disease-free survival as a surrogate endpoint for survival in cancer clinical trials (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    30 June 1999
    0 references
    0 references
    conditional independence
    0 references
    exponential components
    0 references
    colorectal adjuvant clinical trials
    0 references
    0 references